Inhalable Antibiotics Manufactured Through Use of Near-Critical or Supercritical Fluids

REFERENCES

• A. Schulman Inc. 2011 . Additive: Antistatic Reduce Static Charging , A. Schulman Inc. .
   Google Scholar
• Borsje , P. , de Jongste , J. C. , Mouton , J. W. and Tiddens , H. 2000 . Aerosol Therapy in Cystic Fibrosis: A Survey of 54 cf Centers . Pediat. Pulmonology , 30 : 368 – 376 .
   PubMed Web of Science ®Google Scholar
• Bosquillon , C. , Lombry , C. , Preat , V. and Vanbever , R. 2001 . Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance . J. Control. Release , 70 : 329 – 339 .
   PubMed Web of Science ®Google Scholar
• Cape , S. P. , Villa , J. A. , Huang , E. T. S. , Yang , T. H. , Carpenter , J. F. and Sievers , R. E. 2008 . Preparation of Active Proteins, Vaccines and Pharmaceuticals as Fine Powders Using Supercritical or Near-Critical Fluids . Pharm. Res. , 25 : 1967 – 1990 .
   PubMed Web of Science ®Google Scholar
• Chanwong , S. , Maneekarn , N. , Makonkawkeyoon , L. and Makonkawkeyoon , S. 2007 . Intracellular Growth and Drug Susceptibility of Mycobacterium tuberculosis in Macrophages . Tuberculosis , 87 : 130 – 133 .
   PubMed Web of Science ®Google Scholar
• Crowder , T. M. , Rosati , J. A. , Schroeter , J. D. , Hickey , A. J. and Martonen , T. B. 2002 . Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes’ Law And the Particular Relevance to dry Powder Inhaler Formulation and Development . Pharm. Res. , 19 : 239 – 245 .
   PubMed Web of Science ®Google Scholar
• Girling , D. J. 1989 . A Controlled Trial of 3-Month, 4-Month, and 6-Month Regimens of Chemotherapy for Sputum-Smear-Negative Pulmonsrt Tuberculosis-Results at 5 Years . Am. Rev. Respir. Dis. , 139 : 871 – 876 .
   PubMed Web of Science ®Google Scholar
• Giudice , E. L. and Campbell , J. D. 2006 . Needle-Free Vaccine Delivery . Adv. Drug Deliver. Rev. , 58 : 68 – 89 .
   PubMed Web of Science ®Google Scholar
• Heifets , L. 1988 . Mic as a Quantitative Measurement of the Susceptability of Mycobacterium avium Strains to Seven Antituberculosis Drugs . Antimicrob. Agents Ch. , 32 : 1131 – 1136 .
   PubMed Web of Science ®Google Scholar
• Heifets , L. B. , Lindholmlevy , P. J. and Flory , M. 1991 . Comparison of Bacteriostatic and Bactericidal Activity of Isoniazid and Ethionamide Against Mycobacterium avium and Mycobacterium tuberculosis . Am. Rev. Respir. Dis. , 143 : 268 – 270 .
   PubMed Web of Science ®Google Scholar
• Helms , R. , Quan , D. , Herfindal , E. and Gourley , D. 2006 . Textbook of Therapeutics: Drug and Disease Management - 8th ed , Philadelphia : Lippincott Williams & Wilkins .
   Google Scholar
• Hindle , M. and Byron , P. R. 1995 . Dose Emissions from Marketed Dry Powder Inhalers . Int. J. Pharm. , 116 : 169 – 177 .
   Web of Science ®Google Scholar
• Hiyama , J. , Marukawa , M. , Shiota , Y. , Ono , T. and Mashiba , H. 2000 . Factors Influencing Response to Treatment of Pulmonary Tuberculosis . Acta Med. Okayama , 54 : 139 – 145 .
   PubMed Web of Science ®Google Scholar
• Horsburgh , C. R. , Feldman , S. and Ridzon , R. 2000 . Practice Guidelines for the Treatment of Tuberculosis . Clin. Infect. Dis. , 31 : 633 – 639 .
   PubMed Web of Science ®Google Scholar
• Jovanovic , N. , Bouchard , A. , Hofland , G. W. , Witkamp , G. J. , Crommelin , D. J. A. and Jiskoot , W. 2004 . Stabilization of Proteins in dry Powder Formulations Using Supercritical Fluid Technology . Pharm. Res. , 21 : 1955 – 1969 .
   PubMed Web of Science ®Google Scholar
• Kisich , K. O. , Higgins , M. P. , Park , I. , Cape , S. P. , Lindsay , L. Bennett , D. J. 2011 . Dry Powder Measles Vaccine: Particle Deposition, Virus Replication, and Immune Response in Cotton Rats Following Inhalation . Vaccine , 29 : 905 – 912 .
   PubMed Web of Science ®Google Scholar
• Lin , W. H. , Griffin , D. E. , Rota , P. A. , Papania , M. , Cape , S. P. Bennett , D. 2011 . Successful Respiratory Immunization with Dry Powder Live-Attenuated Measles Virus Vaccine in Rhesus Macaques . Proc. Nat. Acad. Sci. U S A , 108 : 2987 – 2992 .
   PubMed Web of Science ®Google Scholar
• May , J. C. , Wheeler , R. M. and Grim , E. 1986 . The Determination of Residual Moisture in Several Freeze-Dried Vaccines and a Honey-Bee Venom Allergenic Extract by tg/ms . J. Therm. Anal. , 31 : 643 – 651 .
   Web of Science ®Google Scholar
• Mitchell , J. , Nagel , M. , Doyle , C. , Ali , R. , Avvakoumova , V. Christopher , J. 2010 . Relative Precision of Inhaler Aerodynamic Particle Size Distribution (apsd) Metrics by Full Resolution and Abbreviated Andersen Cascade Impactors (acis): Part 1 . AAPS Pharm. Sci. Tech. , 11 : 843 – 851 .
   PubMed Web of Science ®Google Scholar
• Mitragotri , S. 2005 . Immunization Without Needles . Nat. Rev. Immunol. , 5 : 905 – 916 .
   PubMed Web of Science ®Google Scholar
• Muttil , P. , Wang , C. C. and Hickey , A. J. 2009 . Inhaled Drug Delivery for Tuberculosis Therapy . Pharm. Res. , 26 : 2401 – 2416 .
   PubMed Web of Science ®Google Scholar
• Namgyal , P. 2006 . Introduction of New Vaccines in the Asia Pacific Region: Challenges and Opportunities . World Health Organization , Geneva
   Google Scholar
• Nuermberger , E. L. , Yoshimatsu , T. , Tyagi , S. , O’Brien , R. J. , Vernon , A. N. Chaisson , R. E. 2004 . Moxifloxacin-Containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis . Am. J. Resp. Crit. Care , 169 : 421 – 426 .
   PubMed Web of Science ®Google Scholar
• Pandey , R. and Khuller , G. K. 2005 . Antitubercular Inhaled Therapy: Opportunities, Progress and Challenges . J. Antimicrob. Chemoth. , 55 : 430 – 435 .
   PubMed Web of Science ®Google Scholar
• Rebits , L. G. , Bennett , D. J. , Bhagwat , P. A. , Morin , A. and Sievers , R. E. 2007 . Method for Quantifying the Sample Collected by an Andersen Cascade Impactor Using Total Organic Carbon Analysis . J. Aerosol Sci. , 38 : 1197 – 1206 .
   Web of Science ®Google Scholar
• Shakoor , O. , Taylor , R. B. and Behrens , R. H. 1997 . Assessment of the Incidence of Substandard Drugs in Developing Countries . Trop. Med. Int. Health , 2 : 839 – 845 .
   PubMed Web of Science ®Google Scholar
• Shin , S. Y. , Furin , J. , Alcantara , F. , Hyson , A. , Joseph , K. Sanchez , E. 2004 . Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis . Chest , 125 : 974 – 980 .
   PubMed Web of Science ®Google Scholar
• Sievers , R. E. , Cape , S. P. , Quinn , B. P. , Searles , J. A. , Best , J. A. Burger , J. L. 2006 . Stabilization, Nebulization, and Near-Ambient Temperature Drying of Measles Vaccine, Igg Antibody, tb Antibiotics, and Zanamivir . Resp. Drug Deliv. X , 2 : 401 – 404 .
   Google Scholar
• Sievers , R. E. , Huang , E. T. S. , Villa , J. A. , Kawamoto , J. K. , Evans , M. M. and Brauer , P. R. 2001 . Low-Temperature Manufacturing of Fine Pharmaceutical Powders with Supercritical Fluid Aerosolization in a Bubble Dryer (r) . Pure Appl. Chem. , 73 : 1299 – 1303 .
   Web of Science ®Google Scholar
• Sievers , R. E. , Quinn , B. P. , Cape , S. P. , Searles , J. A. , Braun , C. S. Bhagwat , P. 2007 . Near-Critical Fluid Micronization of Stabilized Vaccines, Antibiotics and Anti-Virals . J. Supercrit. Fluid , 42 : 385 – 391 .
   Web of Science ®Google Scholar
• Stelmach , R. , Bussamra , M. H. , Rodrigues , J. C. and Cukier , A. 2009 . A Randomized, Comparative Study of Formoterol and Terbutaline Dry Powder Inhalers in the Treatment of Mild to Moderate Asthma Exacerbations in the Pediatric Acute Care Setting . Ann. Allerg. Asthma, Im. , 103 : 248 – 253 .
   PubMed Web of Science ®Google Scholar
• Taylor , R. B. , Shakoor , O. and Behrens , R. H. 1995 . Drug Quality, a Contributor to Drug-Resistance . Lancet , 346 : 122 – 122 .
   PubMed Web of Science ®Google Scholar
• Traini , D. , Adi , H. , Young , P. M. , Chan , H. K. and Agus , H. 2010 . Co-Spray-Dried Mannitol-Ciprofloxacin Dry Powder Inhaler Formulation for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease . Eur. J. Pharm. Sci. , 40 : 239 – 247 .
   PubMed Web of Science ®Google Scholar
• Tyagi , S. , Nuermberger , E. , Yoshimatsu , T. , Williams , K. , Rosenthal , I. Lounis , N. 2005 . Bactericidal Activity of the Nitroimidazopyran pa-824 in a Murine Model of Tuberculosis . Antimicrob. Agents Ch. , 49 : 2289 – 2293 .
   PubMed Web of Science ®Google Scholar
• Varmus , H. , Klausner , R. , Zerhouni , E. , Acharya , T. , Daar , A. S. and Singer , P. A. 2003 . Grand Challenges in Global Health . Science , 302 : 398 – 399 .
   PubMed Web of Science ®Google Scholar
• Vianna , E. O. , Souza , M. L. D. , Meneghini , A. C. , Ferraz , E. and Borges , M. C. 2009 . Knowledge of and Technique for Using Inhalation Devices Among Asthma Patients and Copd Patients . J. Bras. Pneumol. , 35 : 824 – 831 .
   PubMed Web of Science ®Google Scholar
• 2011 . Frequently Asked Questions About tb and hiv . World Health Organization, Geneva, , http://www.who.int/tb/hiv/faq/en/ World Health Organization
   Google Scholar
• Wolf , A. J. , Linas , B. , Trevejo-Nunez , G. J. , Kincaid , E. , Tamura , T. , Takatsu , K. and Ernst , J. D. 2007 . Mycobacterium tuberculosis Infects Dendritic Cells with high Frequency and Impairs Their Function in Vivo . J. Immunol. , 179 : 2509 – 2519 .
   PubMed Web of Science ®Google Scholar